-transparent.png){kind=logo}
The therapeutically important anticoagulant heparin catalyzes inactivation of thrombin by antithrombin III via formation of an intermediary ternary thrombin-heparin-antithrombin III complex that is subsequently converted to a stable thrombin-antithrombin III complex with the release of heparin. Point mutations at Arg-180, Arg-245, Lys-248, and Lys-252 in thrombin markedly reduced the efficiency of heparin catalysis by decreasing the stability of the ternary intermediate, whereas the inactivation of thrombin by antithrombin alone was not affected by these mutations. These results together with an analysis of the x-ray crystal structure of thrombin yielded a model for the thrombin-heparin interaction, wherein heparin forms salt linkages along a groove in thrombin defined by Lys-252, Lys-248, Arg-245, Arg-89, Arg-98, and Arg-180.
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
September 1978,
The Biochemical journal,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
January 1980,
Thrombosis research,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
January 1979,
Thrombosis research,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
August 1977,
Thrombosis and haemostasis,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
May 1989,
Proceedings of the National Academy of Sciences of the United States of America,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
January 1977,
Haematologia,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
December 1976,
Thrombosis and haemostasis,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
October 1986,
The Journal of biological chemistry,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
January 1980,
Thrombosis research,
Z R Gan, and
Y Li, and
Z Chen, and
S D Lewis, and
J A Shafer
May 1984,
The Journal of biological chemistry,
